Refractory Status Epileptics Drugs Market Sees Innovation with IV...

bir ses eklendi Health

2025-09-18 10:51:06

Refractory Status Epileptics Drugs Market Sees Innovation with IV Ganaxolone and Novel Anesthetic Agents.

The global Refractory Status Epileptics Drugs Market is experiencing steady growth, driven by the rising incidence of refractory status epilepticus (RSE), a severe neurological emergency characterized by persistent seizures unresponsive to initial treatments like benzodiazepines. RSE affects up to 40% of status epilepticus cases, often linked to acute symptomatic etiologies such as infections...

0 Yorumlar 0 hisse senetleri 214 Views 0 önizleme